Competing risks and cancer-specific mortality: why it matters
Oncotarget
.
2017 Dec 28;9(7):7272-7273.
doi: 10.18632/oncotarget.23729.
eCollection 2018 Jan 26.
Authors
Kay See Tan
1
,
Takashi Eguchi
1
,
Prasad S Adusumilli
1
Affiliation
1
Prasad S. Adusumilli: Memorial Sloan Kettering Cancer Center, New York, NY, USA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
PMID:
29484108
PMCID:
PMC5800900
DOI:
10.18632/oncotarget.23729
No abstract available
Keywords:
Kaplan-Meier; competing risks; cumulative incidence; lung cancer; survival.